PRESS RELEASE published on 07/18/2024 at 17:56, 1 year 4 months ago Inside Information / News release on accounts, results Median Technologies reports record iCRO backlog and eyonis™ LCS on-track for pivotal study readout in August. Revenue at €10.9 million, cash at €16 million. CEO to provide update via webcast on July 24, 2024 Revenue Growth Median Technologies ICRO Eyonis LCS Pivotal Study
PRESS RELEASE published on 07/18/2024 at 17:56, 1 year 4 months ago Informations privilégiées / Communiqué sur comptes, résultats Median Technologies annonce un carnet de commandes record et les résultats de l'étude eyonis LCS. Chiffre d'affaires semestriel à 10,9 m€, vision et opportunités de croissance en iCRO. Webcast avec le CEO le 24/07/2024 Chiffre D'affaires Carnet De Commandes Median Technologies ICRO Eyonis LCS
BRIEF published on 06/07/2024 at 17:50, 1 year 5 months ago Modifications des droits de vote des actionnaires chez Median Technologies Droit De Vote Partage Le Capital Technologies Médianes Actions Sans Droit De Vote Réglementation Française
BRIEF published on 06/07/2024 at 17:50, 1 year 5 months ago Changes in Shareholder Voting Rights at Median Technologies Share Capital Voting Rights French Regulations Median Technologies Non-voting Shares
PRESS RELEASE published on 06/07/2024 at 17:45, 1 year 5 months ago Modification des droits attachés aux catégories d'actions Déclaration du nombre de droits de vote et d'actions de Median Technologies au 31 mai 2024. Découvrez les chiffres clés de l'entreprise et ses activités dans l'imagerie médicale et l'IA Euronext Growth Imagerie Médicale Intelligence Artificielle Oncologie Median Technologies
PRESS RELEASE published on 06/07/2024 at 17:45, 1 year 5 months ago Changes in the rights attaching to the classes of shares or securities Median Technologies discloses total voting rights and share capital as of May 31, 2024, in compliance with French regulations. The company specializes in AI-driven solutions for cancer diagnosis and treatment Share Capital Voting Rights AI Solutions Median Technologies Cancer Diagnosis
BRIEF published on 05/29/2024 at 17:50, 1 year 6 months ago Median Technologies to Attend 2024 ASCO Annual Meeting in Chicago Clinical Trials Oncology Imaging Solutions Median Technologies ASCO Annual Meeting
BRIEF published on 05/29/2024 at 17:50, 1 year 6 months ago Median Technologies participera à la réunion annuelle de l'ASCO 2024 à Chicago Solutions D'imagerie Essais Cliniques Oncologie Technologies Médianes Réunion Annuelle De L'ASCO
PRESS RELEASE published on 05/29/2024 at 17:45, 1 year 6 months ago Inside Information / Other news releases Median Technologies to participate in the 2024 ASCO Annual Meeting at McCormick Place, Chicago, IL, USA. Abstract on double reading performance in lung clinical trials. Event details and company overview Clinical Trials Oncology Medical Imaging Median Technologies ASCO Annual Meeting
BRIEF published on 05/21/2024 at 17:50, 1 year 6 months ago Median Technologies strengthens its position with pharmaceutical giants Artificial Intelligence Oncology Medical Imaging Median Technologies Clinical Tests
Published on 12/05/2025 at 02:35, 8 hours 11 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 9 hours 46 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 41 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 46 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 10:30, 16 minutes ago Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 31 minutes ago Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 1 hour 5 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 16 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 40 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 2 hours 1 minute ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 2 hours 1 minute ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 2 hours 3 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 16 hours 31 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 16 hours 46 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
